Depression in Parkinson's disease

Canadian Journal of Neurological Sciences

Volumn 37, Issue 1, 2010, Pages 61-66

  Jasinska Myga, Barbara ^a,b   Putzke, John D ^a   Wider, Christian ^a   Wszolek, Zbigniew K ^a   Uitti, Ryan J ^a  

^a MAYO CLINIC   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; BROMOCRIPTINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADL DISABILITY; ADULT; AGED; ARTICLE; CAREGIVER; CLINICAL ASSESSMENT; COGNITION; DEGENERATIVE DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FAMILY; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SPOUSE;

EID: 76649105089     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009665     Document Type: Article

References (39)

1. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183-9; quiz 313.
2. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol. 1996;53(2):175-179
3. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry. 1992;149(4):443-454
4. Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand. 2001;104(5):380-386
5. Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord. 2003;18(4): 414-418
6. Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, et al. Depression and Parkinson's disease. J Neurol. 2004;251 Suppl 6:VI/24-7.
7. Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69(4):342-347
8. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc. 2004;52(5):784-788
9. Cole SA,Woodard JL, Juncos JL, Kogos JL, Youngstrom EA,Watts RL. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1996;8(1):20-25
10. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55(5):377-382
11. Kuopio AM, Marttila RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson's disease. Mov Disord. 2000;15(2): 216-223
12. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000;69(3):308-312
13. Slawek J, Derejko M, Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson's disease--a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord. 2005;11(7):465-468
14. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004;110(2):118-123
15. Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol. 2003;16(3):178-183
16. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2002;8(3): 193-197
17. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Parkinsonism Relat Disord. 2005;11(3): 139-145
18. de Rijk MC, RoccaWA, Anderson DW, Melcon MO, Breteler MM, Maraganore DM. A population perspective on diagnostic criteria for Parkinson's disease. Neurology. 1997;48(5):1277-1281
19. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol. 1990;53:245-249
20. Rodriguez-Oroz MC, Gorospe A, Guridi J, Ramos E, Linazasoro G, Rodriguez-Palmero M, et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology. 2000; 55(12 Suppl 6):S45-51.
21. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology. 1999;53(1): 85-90.
22. Krause M, Fogel W, Heck A, Hacke W, Bonsanto M, Trenkwalder C, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry. 2001;70(4):464-470
23. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne D, editors. Recent developments in Parkinson's disease, Volume 2. Florham Park, NJ: Macmillan; 1987. p. 153-163
24. Hoehn M, Yahr M. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-432
25. Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana S. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord. 2003;10(1):23-28
26. Schoevers RA, BeekmanAT, Deeg DJ, Geerlings MI, Jonker C, Van Tilburg W. Risk factors for depression in later life; results of a prospective community based study (AMSTEL). J Affect Disord. 2000;59(2):127-137
27. Beekman AT, Deeg DJ, van Tilburg T, Smit JH, Hooijer C, van Tilburg W. Major and minor depression in later life: a study of prevalence and risk factors. J Affect Disord. 1995;36(1-2):65-75.
28. Leentjens AF, Lousberg R, Verhey FR. Markers for depression in Parkinson's disease. Acta Psychiatr Scand. 2002;106(3):196-201.
29. Tandberg E, Larsen JP, Aarsland D, Laake K, Cummings JL. Risk factors for depression in Parkinson disease. Arch Neurol. 1997; 54(5):625-630
30. Brown RG, MacCarthy B, Gotham AM, Der GJ, Marsden CD. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med. 1988;18(1):49-55.
31. Palhagen SE, Carlsson M, Curman E, Walinder J, Granerus AK. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process? Acta Neurol Scand. 2008;117(5):295-304.
32. Chia LG, Cheng LJ, Chuo LJ, Cheng FC, Cu JS. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson's disease. J Neurol Sci. 1995;133(1-2):73-78
33. Cubo E, Bernard B, Leurgans S, Raman R. Cognitive and motor function in patients with Parkinson's disease with and without depression. Clin Neuropharmacol. 2000;23(6):331-334
34. Houde SC, Mangolds V. Amyotrophic lateral sclerosis: a team approach to primary care. Clin Excell Nurse Pract. 1999;3(6): 337-345
35. Oertel WH, Hoglinger GU, Caraceni T, Girotti F, Eichhorn T, Spottke AE, et al. Depression in Parkinson's disease. An update. Adv Neurol. 2001;86:373-383
36. Tom T, Cummings JL. Depression in Parkinson's disease. Pharmacological characteristics and treatment. Drugs Aging. 1998;12(1):55-74.
37. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 1981;31(6): 645-650
38. Wichowicz HM, Slawek J, Derejko M, Cubala WJ. Factors associated with depression in Parkinson's disease: a crosssectional study in a Polish population. Eur Psychiatry. 2006;21 (8):516-520
39. Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord. 2006;21(2): 148-158